Amphastar Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AMPH Nasdaq 2830 www.amphastar.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026 - Aug 6th, 2026 3:11 pm
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026 - Aug 6th, 2026 2:05 pm
1 Value Stock to Own for Decades and 2 Facing Challenges - Aug 3rd, 2026 12:29 pm
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Jul 30th, 2026 8:00 am
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 - Jul 29th, 2026 4:00 am
3 Reasons AMPH is Risky and 1 Stock to Buy Instead - Jul 29th, 2026 12:53 am
1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds - Jul 28th, 2026 1:17 pm
3 Stocks Under $50 We Keep Off Our Radar - Jul 22nd, 2026 5:10 am
1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges - Jul 10th, 2026 7:19 am
BridgeBio Pharma (BBIO) Moves 15.1% Higher: Will This Strength Last? - Jul 10th, 2026 3:33 am
BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns - Jun 29th, 2026 10:01 am
New Strong Sell Stocks for June 23rd - Jun 23rd, 2026 3:13 am
1 Healthcare Stock to Consider Right Now and 2 We Brush Off - Jun 12th, 2026 2:54 am
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth - Jun 10th, 2026 5:08 pm
How The Investment Story For Amphastar Pharmaceuticals (AMPH) Is Evolving Without New Valuation Shifts - Jun 9th, 2026 4:17 pm
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag - Jun 3rd, 2026 10:02 pm
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty - Jun 2nd, 2026 8:10 am
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference - May 27th, 2026 4:00 am
3 Stocks Under $50 with Open Questions - May 26th, 2026 4:51 am
Why Wells Fargo Lowered Amphastar Pharmaceuticals, Inc. (AMPH) Price Target to $19 - May 20th, 2026 2:43 pm